Skip to main content
Thorvardur Halfdanarson, MD, Oncology, Rochester, MN, Mayo Clinic Hospital - Rochester

ThorvardurRHalfdanarsonMD

Oncology Rochester, MN

Endocrine Cancer, Gastrointestinal Cancer, Hematologic Oncology

Professor of Oncology, Associate Professor of Medicine, Mayo Clinic, Rochester, Minnesota

Dr. Halfdanarson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Halfdanarson's full profile

Already have an account?

Summary

  • Medical Oncologist with a focus on neuroendocrine and GI oncology.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2003 - 2007
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2000 - 2003
  • University of Iceland
    University of IcelandClass of 1995

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2015 - 2025
  • AZ State Medical License
    AZ State Medical License 2012 - 2025
  • IA State Medical License
    IA State Medical License 2000 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Borderline Resectable and Locally Advanced Pancreas Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Neoadjuvant Therapy Pathologic Response and Prediction of SurvivalOctober 2020

Press Mentions

  • Sharing Mayo Clinic: Georgia Man with Neuroendocrine Cancer Gains Quality of Life Thanks to New Nuclear Med Therapy
    Sharing Mayo Clinic: Georgia Man with Neuroendocrine Cancer Gains Quality of Life Thanks to New Nuclear Med TherapyApril 17th, 2022
  • Georgia Man with Neuroendocrine Cancer Gains Quality of Life Thanks to New Nuclear Med Therapy
    Georgia Man with Neuroendocrine Cancer Gains Quality of Life Thanks to New Nuclear Med TherapyApril 14th, 2022
  • Hyperammonemic Encephalopathy in a Patient with Fibrolamellar Hepatocellular Carcinoma: Case Report and Literature Review
    Hyperammonemic Encephalopathy in a Patient with Fibrolamellar Hepatocellular Carcinoma: Case Report and Literature ReviewJanuary 28th, 2019

Professional Memberships

Hospital Affiliations